RSS Biotech Sector and Stocks Analysis from Seeking Alpha
哪吒推荐该订阅
简介:'biotech' tag rss syndication from seekingalpha.com
原站:http://seekingalpha.com/sector/biotech
点击立即订阅,“Biotech Sector and St...”的内容有更新,哪吒第一时间提醒您
“Biotech Sector and Stocks Analysis from Seeking Alph”的内容更新
累计:3587 篇(自 2008-12-10 起)
更新:约3篇/天,最后更新313 天前
Biotech Sector and Stocks Analysis from Seeking Alpha
bert wilkison submits:on 04/07/11, vertex pharmaceuticals (vrtx) made headlines when it announced that one of its long time collaborators, cystic fibrosis foundation therapeutics, agreed to provide up to $75m over the next five years to support research and development for some of vertex's early stage product candidates in exchange for entitlement to roy... (306 天前)
Biotech Sector and Stocks Analysis from Seeking Alpha
saul kerpelman submits:on march 10, 2011 a federal judge in the southern district of new york issued a ruling in a case involving medicare coverage for "off label" drugs that may come to have tremendous importance for cancer treatments, and specifically for dendreon and its recently fda-approved, revolutionary treatment for prostate cancer, provenge. the... (306 天前)
Biotech Sector and Stocks Analysis from Seeking Alpha
m.e. garza submits: by patrick crutcher with most smallcap biotech companies, investors don't have high expectations for significant revenue from pipeline assets. however, momenta pharmaceuticals (nasdaq: mnta) bucks that trend entirely. considering the size of momenta's revenue stream, we're frankly amazed that they are valued around $750 million. in ... (306 天前)
Biotech Sector and Stocks Analysis from Seeking Alpha
jason chew submits: south san francisco based sunesis (snss) announced a license agreement on april 5 with millennium pharmaceuticals to develop its pan-raf kinase inhibitor. under the terms of this deal, sunesis received $4 million upfront and potentially $60 million in milestones as well as royalties. millennium will pay for all costs of the phase i tr... (306 天前)
Biotech Sector and Stocks Analysis from Seeking Alpha
james stocklasar thomas jr. submits:on 17 march, i wrote that "supergen: flush with cash, but drug pipeline is anemic" sincerely believing that the best way forward for the cash-flush supergen (supg) was to either in-license a later stage drug candidate, or do as they have, execute a merger. as a follow-up, i think this merger is good news for both super... (306 天前)
Biotech Sector and Stocks Analysis from Seeking Alpha
rougemont submits: all of these biotech companies have very substantial amounts of cash or cash equivalents on their balance sheets. they also have either little to no debt. biotechs typically burn through cash and when they don't have enough on hand or have too much debt, it can lead to trouble quick, especially if a new drug doesn't pan out as promised... (306 天前)
Biotech Sector and Stocks Analysis from Seeking Alpha
elan corporation plc (nyse: eln), protalix biotherapeutics inc. (amex: plx) and intermune inc. (nasdaq: itmn) are three top analyst stock picks made during today’s session. elan upgraded and seen as potential takeover target elan corporation (nyse: eln), a neuroscience-based biotechnology company, was upgraded to outperform with a $10.00 per share... (306 天前)
相关订阅源
RSS 月光博客

关于互联网和搜索引擎的it评论博客

标签: 月光博客 it blog web2.0 互联网

指数 | 755人订阅  

RSS Massachusetts Medical Society: New England Journal of Medicine:

Table of Contents for New England Journal of Medicine. List of articles from both the latest and ahead of print issues.

标签: new

指数 | 7人订阅  

RSS ASIA - News and Analysis from Seeking Alpha

'asia' tag rss syndication from seekingalpha.com

标签: opml

指数 | 1人订阅  

RSS Alternative Energy Stocks from Seeking Alpha

'alternative energy' tag rss syndication from seekingalpha.com

标签: opml

指数 | 1人订阅  

我要反馈